» Articles » PMID: 36135330

Exome Sequencing Efficacy and Phenotypic Expansions Involving Esophageal Atresia/tracheoesophageal Fistula Plus

Abstract

Esophageal atresia/tracheoesophageal fistula (EA/TEF) is a life-threatening birth defect that often occurs with other major birth defects (EA/TEF+). Despite advances in genetic testing, a molecular diagnosis can only be made in a minority of EA/TEF+ cases. Here, we analyzed clinical exome sequencing data and data from the DECIPHER database to determine the efficacy of exome sequencing in cases of EA/TEF+ and to identify phenotypic expansions involving EA/TEF. Among 67 individuals with EA/TEF+ referred for clinical exome sequencing, a definitive or probable diagnosis was made in 11 cases for an efficacy rate of 16% (11/67). This efficacy rate is significantly lower than that reported for other major birth defects, suggesting that polygenic, multifactorial, epigenetic, and/or environmental factors may play a particularly important role in EA/TEF pathogenesis. Our cohort included individuals with pathogenic or likely pathogenic variants that affect TCF4 and its downstream target NRXN1, and FANCA, FANCB, and FANCC, which are associated with Fanconi anemia. These cases, previously published case reports, and comparisons to other EA/TEF genes made using a machine learning algorithm, provide evidence in support of a potential pathogenic role for these genes in the development of EA/TEF.

Citing Articles

Long-term outcome of oesophageal atresia in adolescence (TransEAsome): a national French cohort study protocol.

Leroy M, Aumar M, Duhamel M, Dauchet L, Figeac M, Gaillard S BMJ Open. 2025; 15(1):e086303.

PMID: 39800411 PMC: 11749844. DOI: 10.1136/bmjopen-2024-086303.


Esophageal Atresia With or Without Tracheoesophageal Fistula: Comorbidities, Genetic Evaluations, and Neonatal Outcomes.

Khattar D, Suhrie K Cureus. 2023; 15(2):e34779.

PMID: 36909054 PMC: 10005847. DOI: 10.7759/cureus.34779.

References
1.
Robert E, Mutchinick O, Mastroiacovo P, Knudsen L, Daltveit A, Castilla E . An international collaborative study of the epidemiology of esophageal atresia or stenosis. Reprod Toxicol. 1993; 7(5):405-21. DOI: 10.1016/0890-6238(93)90085-l. View

2.
Niguidula N, Alamillo C, Shahmirzadi Mowlavi L, Powis Z, Cohen J, Farwell Hagman K . Clinical whole-exome sequencing results impact medical management. Mol Genet Genomic Med. 2018; 6(6):1068-1078. PMC: 6305629. DOI: 10.1002/mgg3.484. View

3.
Faivre L, Portnoi M, Pals G, Stoppa-Lyonnet D, Le Merrer M, Thauvin-Robinet C . Should chromosome breakage studies be performed in patients with VACTERL association?. Am J Med Genet A. 2005; 137(1):55-8. DOI: 10.1002/ajmg.a.30853. View

4.
Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

5.
Callaway D, Campbell I, Stover S, Hernandez-Garcia A, Jhangiani S, Punetha J . Prioritization of Candidate Genes for Congenital Diaphragmatic Hernia in a Critical Region on Chromosome 4p16 using a Machine-Learning Algorithm. J Pediatr Genet. 2018; 7(4):164-173. PMC: 6234038. DOI: 10.1055/s-0038-1655755. View